Immunotherapy and Biomarkers in Neurodegenerative Disorders

Buch | Hardcover
289 Seiten
2016 | 1st ed. 2016
Humana Press Inc. (Verlag)
978-1-4939-3558-1 (ISBN)

Lese- und Medienproben

Immunotherapy and Biomarkers in Neurodegenerative Disorders -
106,99 inkl. MwSt
With a focus on Alzheimer’s disease, the firstsections of the book examine immunotherapeutic approaches for theaforementioned disease as well as for Parkinson’s disease and Huntington’s disease,amongst others.
This practical volume examines a number of topics
that explore the current status of immunotherapy and diagnostic markers for
neurodegenerative disorders. With a focus on Alzheimer’s disease, the first
sections of the book examine immunotherapeutic approaches for the
aforementioned disease as well as for Parkinson’s disease and Huntington’s disease,
amongst others. The last section of the book covers the importance of biomarker
techniques to catch these diseases early enough for the treatments to be most
useful. Written for the Methods in
Pharmacology and Toxicology series, this book contains the kind of detailed
descriptions and implementation advice that will offer a smooth transition into
the lab.



Authoritative and useful, Immunotherapy and Biomarkers in
Neurodegenerative Disorders aims to aid in the continued progress in the
development of novel immune-based drugs and diagnostic tools for these
devastating brain diseases.

Immunotherapy Against Amyloid-β in Alzheimer’s Disease: An
Overview.- Active Immunization Against the Amyloid-β Peptide.- Immunotherapy
Against N-Truncated Amyloid-β Oligomers.- Immunotherapy Against Amyloid-β
Protofibrils: Opportunities and Challenges.- Immunotherapy Against α-Synuclein
Pathology.- Extracellular α-Synuclein as a Target for Immunotherapy.- Immunotherapy
of Parkinson’s Disease.- Tau
Immunotherapy.- Active and Passive Immunotherapy Against Tau: Effects
and Potential Mechanisms.- Immunotherapy on Experimental Models for
Huntington’s Disease.- Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease.- Volumetric
MRI as a Diagnostic Tool in Alzheimer's Disease.- PET Imaging as a Diagnostic
Tool in Alzheimer´s Disease.- Αlpha-Synuclein as a Diagnostic Biomarker for
Parkinson’s Disease.- Imaging as a Diagnostic Tool in Parkinson’s Disease.- Mass
Spectrometry-Based Proteomics in Biomarker Discovery for Neurodegenerative
Diseases.

Erscheinungsdatum
Reihe/Serie Methods in Pharmacology and Toxicology
Zusatzinfo 32 Illustrations, color; 8 Illustrations, black and white; X, 289 p. 40 illus., 32 illus. in color.
Verlagsort Totowa, NJ
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie
Schlagworte Alzheimer’s disease • Amyloid-Beta • Immunotherapeutic targets • monoclonal antibodies • Parkinson’s disease • tau protein • Therapeutic Antibodies
ISBN-10 1-4939-3558-5 / 1493935585
ISBN-13 978-1-4939-3558-1 / 9781493935581
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
interdisziplinäre Diagnose- und Behandlungsstrategien

von Christoph Maier; Ulrike Bingel; Esther Pogatzki-Zahn

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
97,00